Navigation Links
Solutia Opens New Photovoltaic Laboratory
Date:10/12/2010

SPRINGFIELD, Mass., Oct. 12 /PRNewswire/ -- Solutia Inc. (NYSE: SOA), a market-leading performance materials and specialty chemicals company, has opened a new Photovoltaic Laboratory Center to develop innovative solutions that support the fast-growing solar energy market.

(Logo: http://photos.prnewswire.com/prnh/20081029/AQW096LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081029/AQW096LOGO)

The state-of-the-art facility is a testament to Solutia's commitment to the fast-growing solar energy market and follows a series of recent solar energy investments, including the purchase of Etimex Solar GmbH and planned expansions of its polyvinyl butyral (PVB) interlayer and ethylene vinyl acetate (EVA) encapsulant production in China—branded as Saflex® PVB encapsulant and Vistasolar® EVA encapsulant. The new facility is located in the Indian Orchard part of Springfield, Massachusetts, USA.

"Demand for renewable energy is growing, and that drives the demand for innovative technologies and materials," comments Aristotelis Karagiannis, vice president of technology, Solutia's Advanced Interlayers division. "With our deep understanding of EVA and PVB technologies, a track record of rapid innovation and our new laboratory, we're in a unique position to develop and deliver high-value solutions for the solar module market."

The new facility is designed to spur breakthrough innovations, accelerate new product development timelines and provide expert technical service to the makers of solar modules. The center is operated by a photovoltaic development team of EVA and PVB experts in chemistry, physics, polymer design and formulation and polymer processing.

“We knew that the acquisition of Etimex Solar GmbH was going to provide synergistic opportunities for EVA and PVB product development and support,” said Eric Nichols, vice president, Solutia’s Advanced Interlayers division.  "Our new laboratory houses our experts and provides them with state-of-the-art equipment to drive these technologies plus further enhances our ability to solve customer problems including process improvements."

To help accelerate the commercialization of new products, module manufacturers can utilize Solutia's improved ability to perform key International Electrotechnical Commission (IEC) tests for new module packages prior to formal testing submissions. The laboratory also provides full capabilities for all photovoltaic encapsulation processes and pilot production of encapsulants.

"The new laboratory is a one-stop shop for the development of photovoltaic solutions" Karagiannis said. "It helps put Solutia and our customers on the leading edge of the high-growth renewable energy market."

NOTE TO EDITORS: Solutia, Saflex and Vistasolar are trademarks of Solutia Inc. and/or its subsidiaries. Etimex Solar is a trademark of Etimex Holding GmbH.  

Corporate Profile

Solutia is a market-leading performance materials and specialty chemicals company. The company focuses on providing solutions for a better life through a range of products, including: Saflex® polyvinyl butyral interlayers for glass lamination and for photovoltaic module encapsulation and Vistasolar® ethylene vinyl acetate films for photovoltaic module encapsulation;  LLumar®, Vista™, FormulaOne®, Gila®, EnerLogic™, V-KOOL®, Huper Optik®, IQue™, Sun-X® and Nanolux® aftermarket performance films for automotive and architectural applications; Flexvue™ advanced film component solutions for solar and electronic technologies; and technical specialties products including Crystex® insoluble sulfur, Santoflex® PPD antidegradants, Therminol® heat transfer fluids and Skydrol® aviation hydraulic fluids. Solutia's businesses are world leaders in each of their market segments. With its headquarters in St. Louis, Missouri, USA, the company operates globally with approximately 3,400 employees in more than 50 worldwide locations. More information is available at www.Solutia.com


'/>"/>
SOURCE Solutia Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Solutia to Present at Credit Suisse Future Energy Conference
2. Solutia Reports Third Quarter 2009 Results
3. Solutia Reports First Quarter 2009 Results
4. Solutia to Present at Deutsche Bank Small and Mid Cap Conference
5. MPM Capital Opens Midwest Office
6. Single electron reader opens path for quantum computing
7. Image of new antibiotic in action opens up new opportunities to combat antibacterial resistance
8. Beike Biotechnology Opens First Chinese Rehabilitation Center in Romania
9. PRA International Opens Phase I Unit in Budapest
10. Beike Biotechnology Opens Worlds Largest Stem Cell Storage and Processing Facility
11. Brooks Instrument Opens Pressure Gauge Production Line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Winston-Salem, NC (PRWEB) , ... March 27, 2017 , ... ... Clinical Trial Collaborations (CTC) conference presented by The Conference Forum in Boston ... the way they collaborate to drive improved clinical trial outcomes and bring them closer ...
(Date:3/24/2017)... MARIETTA, Ga. , March 24, 2017 ... and biopharmaceutical company utilizing human placental tissue allografts and ... therapies for multiple sectors of healthcare, announced today  that ... New York , NY.  Parker H. ... , Chief Financial Officer, Christopher M. Cashman , ...
(Date:3/24/2017)... , March 24, 2017   Sienna Biopharmaceuticals, Inc. ... company, today announced that Richard Peterson will ... 24.   Peterson, who brings more than two ... Smither , who is retiring at the end of ... advisory capacity. Peterson joins Sienna from Novan, Inc., where ...
(Date:3/23/2017)... 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), ... for solid tumor cancers, today announced that yesterday ... announced last Friday, March 17, 2017. ... securities totaling 28,843,692 shares, comprised of 18,843,692 common ... of Class C Warrants pre-funded at the closing ...
Breaking Biology Technology:
(Date:3/7/2017)... , March 7, 2017 Brandwatch , the leading ... The Prince,s Trust to uncover insights to support its ... Trust. The UK,s leading youth charity will be using ... results and get a better understanding of the topics and issues ... ...
(Date:3/2/2017)... YORK , March 2, 2017 Summary ... better understand Perrigo and its partnering interests and activities since ... ... Partnering Deals and Alliance since 2010 report provides an in-depth ... leading life sciences companies. On demand company reports ...
(Date:3/2/2017)... , March 2, 2017 Australian stem ... (ASX: CYP), has signed an agreement with the ... the Monash Biomedicine Discovery Institute and Department of Pharmacology ... conduct a further preclinical study to support the use ... of asthma.  Asthma is a chronic, ...
Breaking Biology News(10 mins):